CONTEXT: Folate is involved in DNA synthesis and methylation and may reduce breast cancer risk, particularly among women with greater alcohol consumption. OBJECTIVES: To assess the association between folate intake and risk of breast cancer and whether higher folate intake may reduce excess risk among women who consume alcohol. DESIGN: Prospective cohort study performed in 1980, with 16 years of follow-up. SETTING AND PARTICIPANTS: A total of 88818 women who completed the dietary questionnaire section of the Nurses' Health Study in 1980. MAIN OUTCOME MEASURE: Incidence of invasive breast cancer by levels of folate and alcohol intake. RESULTS: A total of 3483 cases of breast cancer were documented. Total folate intake was not associated with overall risk of breast cancer. However, among women who consumed at least 15 g/d of alcohol, the risk of breast cancer was highest among those with low folate intake. For total folate intake of at least 600 microg/d compared with 150 to 299 microg/d, the multivariate relative risk (RR) was 0.55 (95% confidence interval [CI], 0.39-0.76; P for trend = .001). This association was only slightly attenuated after additional adjustment for intake of beta carotene, lutein/zeaxanthin, preformed vitamin A, and total vitamins C and E. The risk of breast cancer associated with alcohol intake was strongest among women with total folate intake of less than 300 microg/d (for alcohol intake > or =15 g/d vs <15 g/d, multivariate RR, 1.32; 95% CI, 1.15-1.50). For women who consumed at least 300 microg/d of total folate, the multivariate RR for intake of at least 15 g/d of alcohol vs less than 15 g/d was 1.05 (95% CI, 0.92-1.20). Current use of multivitamin supplements, the major source of folate, was associated with lower breast cancer risk among women who consumed at least 15 g/d of alcohol (for current users of supplements vs never users, RR, 0.74; 95% CI, 0.59-0.93). CONCLUSIONS: Our findings suggest that the excess risk of breast cancer associated with alcohol consumption may be reduced by adequate folate intake.
CONTEXT: Folate is involved in DNA synthesis and methylation and may reduce breast cancer risk, particularly among women with greater alcohol consumption. OBJECTIVES: To assess the association between folate intake and risk of breast cancer and whether higher folate intake may reduce excess risk among women who consume alcohol. DESIGN: Prospective cohort study performed in 1980, with 16 years of follow-up. SETTING AND PARTICIPANTS: A total of 88818 women who completed the dietary questionnaire section of the Nurses' Health Study in 1980. MAIN OUTCOME MEASURE: Incidence of invasive breast cancer by levels of folate and alcohol intake. RESULTS: A total of 3483 cases of breast cancer were documented. Total folate intake was not associated with overall risk of breast cancer. However, among women who consumed at least 15 g/d of alcohol, the risk of breast cancer was highest among those with low folate intake. For total folate intake of at least 600 microg/d compared with 150 to 299 microg/d, the multivariate relative risk (RR) was 0.55 (95% confidence interval [CI], 0.39-0.76; P for trend = .001). This association was only slightly attenuated after additional adjustment for intake of beta carotene, lutein/zeaxanthin, preformed vitamin A, and total vitamins C and E. The risk of breast cancer associated with alcohol intake was strongest among women with total folate intake of less than 300 microg/d (for alcohol intake > or =15 g/d vs <15 g/d, multivariate RR, 1.32; 95% CI, 1.15-1.50). For women who consumed at least 300 microg/d of total folate, the multivariate RR for intake of at least 15 g/d of alcohol vs less than 15 g/d was 1.05 (95% CI, 0.92-1.20). Current use of multivitamin supplements, the major source of folate, was associated with lower breast cancer risk among women who consumed at least 15 g/d of alcohol (for current users of supplements vs never users, RR, 0.74; 95% CI, 0.59-0.93). CONCLUSIONS: Our findings suggest that the excess risk of breast cancer associated with alcohol consumption may be reduced by adequate folate intake.
Authors: Zhihong Gong; Christine B Ambrosone; Susan E McCann; Gary Zirpoli; Urmila Chandran; Chi-Chen Hong; Dana H Bovbjerg; Lina Jandorf; Gregory Ciupak; Karen Pawlish; Quanjun Lu; Helena Hwang; Thaer Khoury; Bshara Wiam; Elisa V Bandera Journal: Int J Cancer Date: 2013-09-30 Impact factor: 7.396
Authors: David A Hanauer; Mohammed Saeed; Kai Zheng; Qiaozhu Mei; Kerby Shedden; Alan R Aronson; Naren Ramakrishnan Journal: J Am Med Inform Assoc Date: 2014-06-13 Impact factor: 4.497
Authors: Kerryn W Reding; Janet R Daling; David R Doody; Cecilia A O'Brien; Peggy L Porter; Kathleen E Malone Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-07-29 Impact factor: 4.254
Authors: Christine M Duffy; Annlouise Assaf; Michele Cyr; Gary Burkholder; Elizabeth Coccio; Tom Rohan; Anne McTiernan; Electra Paskett; Dorothy Lane; V K Chetty Journal: Breast Cancer Res Treat Date: 2008-09-11 Impact factor: 4.872
Authors: Seungyoun Jung; Molin Wang; Kristin Anderson; Laura Baglietto; Leif Bergkvist; Leslie Bernstein; Piet A van den Brandt; Louise Brinton; Julie E Buring; A Heather Eliassen; Roni Falk; Susan M Gapstur; Graham G Giles; Gary Goodman; Judith Hoffman-Bolton; Pamela L Horn-Ross; Manami Inoue; Laurence N Kolonel; Vittorio Krogh; Marie Lof; Paige Maas; Anthony B Miller; Marian L Neuhouser; Yikyung Park; Kim Robien; Thomas E Rohan; Stephanie Scarmo; Leo J Schouten; Sabina Sieri; Victoria L Stevens; Schoichiro Tsugane; Kala Visvanathan; Lynne R Wilkens; Alicja Wolk; Elisabete Weiderpass; Walter C Willett; Anne Zeleniuch-Jacquotte; Shumin M Zhang; Xuehong Zhang; Regina G Ziegler; Stephanie A Smith-Warner Journal: Int J Epidemiol Date: 2015-08-28 Impact factor: 7.196